Madeline E. Kavanagh

Madeline E. Kavanagh

Auto-generated profile, based on publicly available information

Madeline E. Kavanagh

Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2021 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
MAMikail E. Abbasov
Mikail E. Abbasov
MKMadeline E. Kavanagh
Madeline E. Kavanagh
TITaka-Aki Ichu
Taka-Aki Ichu
MLMichael R. Lazear
Michael R. Lazear
YTYongfeng Tao
Yongfeng Tao
BCBenjamin F. Cravatt
Benjamin F. Cravatt

13 December 2021 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
JBJurgen Brem
Jurgen Brem
TPTharindi Panduwawala
Tharindi Panduwawala
JHJon Ulf Hansen
Jon Ulf Hansen
JHJoanne Hewitt
Joanne Hewitt
ELEdgars Liepins
Edgars Liepins
CSChristopher J. Schofield
Christopher J. Schofield

12 September 2022 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
MKMadeline E. Kavanagh
Madeline E. Kavanagh
BHBenjamin D. Horning
Benjamin D. Horning
RKRoli Khattri
Roli Khattri
NRNilotpal Roy
Nilotpal Roy
JLJustine P. Lu
Justine P. Lu
BCBenjamin F. Cravatt
Benjamin F. Cravatt
The Janus tyrosine kinase (JAK) family of non-receptor tyrosine kinases includes four isoforms (JAK1, JAK2, JAK3, and TYK2) and is responsible for signal transduction downstream of diverse cytokine receptors. JAK inhibitors have emerged as important therapies for immun(onc)ological disorders, but their use is limited by undesirable side effects presumed to arise from poor isoform selectivity, a common challenge for inhibitors targeting the ATP-binding pocket of kinases. Here we describe the chemical proteomic discovery of a druggable allosteric cysteine present in the non-catalytic pseudokinase domain of JAK1 (C817) and TYK2 (C838), but absent from JAK2 or JAK3. Electrophilic compounds selectively engaging this site block JAK1-dependent trans-phosphorylation and cytokine signaling, while appearing to act largely as ‘silent’ ligands for TYK2. Importantly, the allosteric JAK1 inhibitors do not impair JAK2-dependent cytokine signaling and are inactive in cells expressing a C817A JAK1 mutant. Our findings thus reveal an allosteric approach for inhibiting JAK1 with unprecedented isoform selectivity.

21 July 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
GAGloria Asantewaa
Gloria Asantewaa
ETEmily T Tuttle
Emily T Tuttle
NWNathan P Ward
Nathan P Ward
YKYun Pyo Kang
Yun Pyo Kang
YKYumi Kim
Yumi Kim
IHIsaac S Harris
Isaac S Harris
Cells rely on antioxidants to survive. The most abundant antioxidant is glutathione (GSH). The synthesis of GSH is non-redundantly controlled by the glutamate-cysteine ligase catalytic subunit (GCLC). GSH imbalance is implicated in many diseases, but the requirement for GSH in adult tissues is unclear. To interrogate this, we have developed a series of in vivo models to induce Gclc deletion in adult animals. We find that GSH is essential to lipid abundance in vivo. GSH levels are highest in liver tissue, which is also a hub for lipid production. While the loss of GSH does not cause liver failure, it decreases lipogenic enzyme expression, circulating triglyceride levels, and fat stores. Mechanistically, we find that GSH promotes lipid abundance by repressing NRF2, a transcription factor induced by oxidative stress. These studies identify GSH as a fulcrum in the liver’s balance of redox buffering and triglyceride production.

25 August 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
DCDaniel S.-H. Chan
Daniel S.-H. Chan
MKMadeline E. Kavanagh
Madeline E. Kavanagh
KMKirsty J McLean
Kirsty J McLean
AMAndrew W Munro
Andrew W Munro
DMDijana Matak-Vinković
Dijana Matak-Vinković
CAChris Abell
Chris Abell

1 August 2016 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
HDHolly J. Davis
Holly J. Davis
MKMadeline E. Kavanagh
Madeline E. Kavanagh
TBTudor Balan
Tudor Balan
CAChris Abell
Chris Abell
ACAnthony G. Coyne
Anthony G. Coyne